Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04XVJ
|
|||
| Former ID |
DIB003592
|
|||
| Drug Name |
LEO-29102
|
|||
| Indication | Atopic dermatitis [ICD-11: EA80; ICD-10: L20; ICD-9: 691.8, 692.9] | Phase 2 | [1] | |
| Company |
LEO Pharma A/S
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H22Cl2N2O5
|
|||
| Canonical SMILES |
CCCNC(=O)COC1=C(C=CC(=C1OC)OC)C(=O)CC2=C(C=NC=C2Cl)Cl
|
|||
| InChI |
1S/C20H22Cl2N2O5/c1-4-7-24-18(26)11-29-19-12(5-6-17(27-2)20(19)28-3)16(25)8-13-14(21)9-23-10-15(13)22/h5-6,9-10H,4,7-8,11H2,1-3H3,(H,24,26)
|
|||
| InChIKey |
HOKIHKLKOZWCRY-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1035572-38-3
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01037881) LEO 29102 Cream in the Treatment of Atopic Dermatitis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.